NO20084009L - Amidderivat eller salt derav - Google Patents

Amidderivat eller salt derav

Info

Publication number: NO20084009L
Authority: NO; Norway
Prior art keywords: receptor; treatment; compound; amide derivative; ibs
Prior art date: 2006-02-20

Application number

NO20084009A

Other languages

English (en)

Norwegian (no)

Inventor

Hiroyoshi Yamada

Shinobu Akuzawa

Daisuke Kaga

Hidetaka Kaku

Ryushi Seo

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-20

Filing date

2008-09-19

Publication date

2008-10-30

2008-09-19 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2008-10-30 Publication of NO20084009L publication Critical patent/NO20084009L/no

Links

150000001408 amides Chemical class 0.000 title abstract 2
150000003839 salts Chemical class 0.000 title abstract 2
208000002551 irritable bowel syndrome Diseases 0.000 abstract 4
108091005436 5-HT7 receptors Proteins 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 3
108020003175 receptors Proteins 0.000 abstract 3
102000005962 receptors Human genes 0.000 abstract 3
102000006969 5-HT2B Serotonin Receptor Human genes 0.000 abstract 2
108010072584 5-HT2B Serotonin Receptor Proteins 0.000 abstract 2
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
230000003042 antagnostic effect Effects 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
230000002265 prevention Effects 0.000 abstract 2
239000005557 antagonist Substances 0.000 abstract 1
125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Indole Compounds (AREA)
Quinoline Compounds (AREA)

NO20084009A 2006-02-20 2008-09-19 Amidderivat eller salt derav NO20084009L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2006041827		2006-02-20
PCT/JP2007/052109 WO2007097197A1 (ja)	2006-02-20	2007-02-07	アミド誘導体またはその塩

Publications (1)

Publication Number	Publication Date
NO20084009L true NO20084009L (no)	2008-10-30

Family

ID=38437237

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20084009A NO20084009L (no)	2006-02-20	2008-09-19	Amidderivat eller salt derav

Country Status (15)

Country	Link
US (1)	US7985764B2 (pt)
EP (1)	EP1988076A4 (pt)
JP (1)	JP5157892B2 (pt)
KR (1)	KR20080094962A (pt)
CN (1)	CN101384550B (pt)
AU (1)	AU2007218781A1 (pt)
BR (1)	BRPI0707979A2 (pt)
CA (1)	CA2642610A1 (pt)
IL (1)	IL193422A0 (pt)
MX (1)	MX2008010645A (pt)
NO (1)	NO20084009L (pt)
RU (1)	RU2008137612A (pt)
TW (1)	TW200808310A (pt)
WO (1)	WO2007097197A1 (pt)
ZA (1)	ZA200806983B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6738561B1 (en)	1997-11-21	2004-05-18	Victor Company Of Japan, Ltd.	Recording medium and signal processing apparatus
WO2006085510A1 (ja) *	2005-02-08	2006-08-17	Astellas Pharma Inc.	過敏性腸症候群の治療薬
CA2617473A1 (en) *	2005-08-08	2007-02-15	Astellas Pharma Inc.	Acylguanidine derivative or salt thereof
EP1988075B1 (en) *	2006-02-20	2012-01-25	Astellas Pharma Inc.	Pyrrole derivative or salt thereof
TW201116281A (en)	2009-08-06	2011-05-16	Astellas Pharma Inc	N atom containing ring acylguanidine derivatives
KR20130059400A (ko)	2010-08-25	2013-06-05	(주)네오팜	신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물
DK2669270T3 (en)	2011-01-28	2018-02-26	Sato Pharma	Indole-related compounds such as URAT1 inhibitors
US9051265B2 (en) *	2011-06-06	2015-06-09	The Scripps Research Institute	N-benzylindole modulators of PPARG
US8957093B2 (en)	2011-06-06	2015-02-17	The Scripps Research Institute	N-biphenylmethylindole modulators of PPARG
EP2573558A1 (en) *	2011-09-23	2013-03-27	Philip Morris Products S.A.	Modulation of G protein-mediated signal transduction pathways
US9309227B2 (en)	2011-11-22	2016-04-12	The Scripps Research Institute	N-biphenylmethylbenzimidazole modulators of PPARG
CN103772278A (zh) *	2014-01-02	2014-05-07	湖南华腾制药有限公司	一种重要四氢异喹啉衍生物中间体及其合成方法
KR101585605B1 (ko) *	2014-03-20	2016-01-21	현대약품 주식회사	Pparg에 결합하되 증진제로 작용하지 않는 화합물 및 이를 유효성분으로 함유하는 pparg 관련 질병의 치료용 약학적 조성물
WO2015161108A1 (en)	2014-04-16	2015-10-22	The Scripps Research Institute	Pparg modulators for treatment of osteoporosis
EP3109237A1 (en)	2015-06-22	2016-12-28	AnaMar AB	Novel 5-ht2 antagonists
CN105175309A (zh) *	2015-10-29	2015-12-23	中国科学院上海药物研究所	N-苄基-5/6-甲酰氨基吲哚-2-羧酸衍生物及其用途
PL3947360T3 (pl) *	2019-03-28	2024-11-04	Zoetis Services Llc	Związki hamujące receptor serotoninowy 5-HT2B
EP3753924A1 (en)	2019-06-18	2020-12-23	AnaMar AB	New tricyclic 5-ht2 antagonists
US20240066027A1 (en) *	2020-12-03	2024-02-29	Domain Therapeutics	Novel par-2 inhibitors

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8524157D0 (en) *	1984-10-19	1985-11-06	Ici America Inc	Heterocyclic amides
JP3162572B2 (ja)	1993-04-28	2001-05-08	住友製薬株式会社	インドロイルグアニジン誘導体
CA2121391A1 (en)	1993-04-28	1994-10-29	Atsuyuki Kojima	Indoloylguanidine derivatives
US5852046A (en) *	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
EP0639573A1 (de) *	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
JP3295277B2 (ja) *	1994-06-01	2002-06-24	呉羽化学工業株式会社	抗腎疾患剤及びベンズイミダゾール誘導体
CA2217707A1 (en)	1995-04-10	1996-10-17	Fujisawa Pharmaceutial Co., Ltd.	Indole derivatives as cgmp-pde inhibitors
AUPO118896A0 (en)	1996-07-23	1996-08-15	Fujisawa Pharmaceutical Co., Ltd.	New use
JPH10114654A (ja)	1996-10-09	1998-05-06	Fujisawa Pharmaceut Co Ltd	新規用途
ES2200163T3 (es) *	1996-11-15	2004-03-01	Darwin Discovery Limited	Aril-carboxamidas biciclicas y su utilizacion terapeutica.
GB9721139D0 (en) *	1997-10-07	1997-12-03	Glaxo Group Ltd	Medicaments
DK1032556T3 (da)	1997-10-21	2008-03-25	Wyeth Corp	Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
US6358992B1 (en)	1998-11-25	2002-03-19	Cell Pathways, Inc.	Method of inhibiting neoplastic cells with indole derivatives
WO2000069437A1 (en)	1999-05-18	2000-11-23	Synaptic Pharmaceutical Corporation	Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder
US6534535B1 (en)	1999-08-12	2003-03-18	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
DE19939463A1 (de) *	1999-08-20	2001-02-22	Boehringer Ingelheim Pharma	Aminocarbonyl-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
MY125942A (en)	1999-09-07	2006-09-29	Upjohn Co	Aminoalkoxy carbazoles for the treatment of cns diseases
SE0301699D0 (sv)	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2005162657A (ja) *	2003-12-02	2005-06-23	Takeda Chem Ind Ltd	カンナビノイド受容体調節剤
JPWO2005079845A1 (ja)	2004-02-20	2007-08-02	アステラス製薬株式会社	片頭痛予防薬
BRPI0506139A (pt)	2004-02-20	2006-10-24	Astellas Pharma Inc	derivados fluoreno
WO2006085510A1 (ja) *	2005-02-08	2006-08-17	Astellas Pharma Inc.	過敏性腸症候群の治療薬
CA2617473A1 (en)	2005-08-08	2007-02-15	Astellas Pharma Inc.	Acylguanidine derivative or salt thereof

2007
- 2007-02-07 WO PCT/JP2007/052109 patent/WO2007097197A1/ja not_active Ceased
- 2007-02-07 MX MX2008010645A patent/MX2008010645A/es active IP Right Grant
- 2007-02-07 BR BRPI0707979-6A patent/BRPI0707979A2/pt not_active IP Right Cessation
- 2007-02-07 CA CA002642610A patent/CA2642610A1/en not_active Abandoned
- 2007-02-07 EP EP07708148.7A patent/EP1988076A4/en not_active Withdrawn
- 2007-02-07 US US12/279,221 patent/US7985764B2/en not_active Expired - Fee Related
- 2007-02-07 RU RU2008137612/04A patent/RU2008137612A/ru not_active Application Discontinuation
- 2007-02-07 ZA ZA200806983A patent/ZA200806983B/xx unknown
- 2007-02-07 KR KR1020087022899A patent/KR20080094962A/ko not_active Ceased
- 2007-02-07 CN CN2007800059681A patent/CN101384550B/zh not_active Expired - Fee Related
- 2007-02-07 JP JP2008501670A patent/JP5157892B2/ja not_active Expired - Fee Related
- 2007-02-07 AU AU2007218781A patent/AU2007218781A1/en not_active Abandoned
- 2007-02-14 TW TW096105567A patent/TW200808310A/zh unknown
2008
- 2008-08-13 IL IL193422A patent/IL193422A0/en unknown
- 2008-09-19 NO NO20084009A patent/NO20084009L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN101384550B (zh)	2011-08-31
MX2008010645A (es)	2008-10-14
CN101384550A (zh)	2009-03-11
EP1988076A1 (en)	2008-11-05
KR20080094962A (ko)	2008-10-27
US20090062363A1 (en)	2009-03-05
US7985764B2 (en)	2011-07-26
TW200808310A (en)	2008-02-16
BRPI0707979A2 (pt)	2011-05-17
EP1988076A4 (en)	2013-09-04
ZA200806983B (en)	2009-11-25
JP5157892B2 (ja)	2013-03-06
IL193422A0 (en)	2009-05-04
RU2008137612A (ru)	2010-03-27
WO2007097197A1 (ja)	2007-08-30
CA2642610A1 (en)	2007-08-30
JPWO2007097197A1 (ja)	2009-07-09
AU2007218781A1 (en)	2007-08-30

Legal Events

Date	Code	Title	Description
2012-10-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20084009L (no)	2008-10-30	Amidderivat eller salt derav
WO2008048981A3 (en)	2008-09-18	Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
TW200640867A (en)	2006-12-01	Pyridine-3-carboxamide derivatives as CB1 inverse agonists
NO20085099L (no)	2009-02-16	Puritonderivativer som HM74A agonister
MA32467B1 (fr)	2011-07-03	Derives de piperidinyle agonistes de gpcr
WO2007150025A3 (en)	2008-02-07	Purinone derivatives as hm74a agonists
NO20063620L (no)	2006-10-06	Arylanilinderivater som beta2 adrenergiske receptoragonister
MX2018003929A (es)	2018-11-22	Fármacos anti-estrogénicos tetrahidro-1h-pirido [3,4-b] indol.
DK2522667T3 (da)	2014-11-03	Morphinanforbindelser
EP2328414A4 (en)	2011-11-16	SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES
NO20084435L (no)	2008-11-28	C-MET proteinkinaseinhibitorer
NO20092376L (no)	2009-06-22	Sfingosin-1-fosfat-reseptoragonist og -antagonistforbindelser
NO20084912L (no)	2009-02-03	Bisykliske derivater som CETP-inhibitorer
NO20083923L (no)	2008-11-04	Pyrazolkinoloner er potente parp-inhibitorer
MX2008013196A (es)	2008-10-22	5-amido-2-carboxiamida-indoles.
UA92670C2 (ru)	2010-11-25	Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
WO2009024823A3 (en)	2009-04-16	Cyclopropyl amide derivatives
TW200616953A (en)	2006-06-01	Indole, indazole or indoline derivatives
IL182365A0 (en)	2007-07-24	5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders
NO20080392L (no)	2008-02-28	Pyrazolpyridinderivater som inhibitorer av beta-adrenergisk receptorkinase 1
WO2010120695A3 (en)	2010-12-02	5-ht4 receptor agonist compounds for treatment of cognitive disorders
WO2007064553A3 (en)	2008-07-10	Thiazole derivatives as cxcr3 receptor modulators
NO20080033L (no)	2008-01-03	Kinolinderivater som NK3-antagonister
ATE496918T1 (de)	2011-02-15	Als a2b-adenosinrezeptorantagonisten geeignete 5- phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4, - büpyridin-2-onderivate
EA200870454A1 (ru)	2009-04-28	Способ ингибирования c-kit киназы